Arlington Trust’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
WA
CAM
RP
PCM
EOJOAM
CF
MNBTD
GIA
Arlington Trust's RGEN Position: Q2 2026 in Review
Arlington Trust increased its Repligen (RGEN) stake by 98% in Q2 2026, buying an estimated $5.53K and bringing the position to 91 shares worth $12.4K. The position accounts for ﹤0.01% of the portfolio, ranked #439.
Arlington Trust first reported a position in RGEN in Q3 2024 and has held it in 5 quarters since. 64 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- Arlington Trust held 91 shares of Repligen worth $12.4K as of Q2 2026.
- Arlington Trust bought 45 Repligen shares in Q2 2026, an estimated $5.53K.
- Repligen made up ﹤0.01% of Arlington Trust's portfolio in Q2 2026, its #439 holding.
- Arlington Trust first reported a position in Repligen in Q3 2024 and has held it in 5 quarters since.
- 64 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.